The current sibutramine label cautions against its use in patients with a history of cardiovascular disease, but the warning will now be more specific, including those with a history of coronary artery disease, heart attack, or angina; stroke or transient ischemic attack; arrhythmia (irregular heart beat); congestive heart failure; peripheral arterial disease; or uncontrolled hypertension more than 145/90 mmHg. Additionally, the FDA says patients currently using sibutramine should talk with their healthcare provider to determine if continued use of the drug is appropriate and discuss any questions or concerns they may have.
No comments:
Post a Comment